Abstract/Late-breaking Guidelines & FAQs

• The research is limited to highly significant and timely subject matter that was not available by the Oct. 25, 2022 abstract submission deadline for 2023 AANS Annual Scientific Meeting.
• Only abstracts deemed of high scientific priority and which merit presentation are part of the late-breaking abstract category.
• Late-breaking abstracts cannot be a revision of an abstract submitted during 2023 AANS Annual Scientific Meeting Abstract Center submission period.
• Late-breaking abstracts must not have been submitted, presented, accepted for presentation or published in any other scientific venue.
• Authors may submit only one abstract for a late-breaking session.

Visit abstractscorecard.com and log in using your MyAANS username and password to submit an abstract.

• Abstract Title — Titles should read as you want it to appear in meeting publications. Use title case capitalization, do not use all CAPITAL LETTERS and do not put a period at the end of the title. Example: This is a Properly Formatted Abstract Title
• Presentation Preference — Please note whether the preferred format is an oral presentation, poster or both. Note: Selecting “Oral Only” is indicating your preferred choice and is not a guarantee. Late-breaking Preference is listed Late-breaking only.
• Presenting Author (First Author) — Individual who is submitting the abstract and is required to register and attend the meeting.
  • The presenting author must submit under their own account.
  • The presenting author is expected to present, if chosen. Presenting author account information/status at the time of submission is used to determine award eligibility.
  • All correspondence is done via email with the presenting author.
• Co-authors — List full names with credentials and email addresses.
• Primary and Secondary Subject Categories
• Abstract Body — Include introduction, methods, results and conclusion sections. Text is limited to 300 words.
• Additional Information — This includes elements such as previous presentation of abstract, FDA approval, industry employment status, medical student/resident designation, senior author information, funding/database questions and award consideration. Note: Check the appropriate box(es) to be considered for awards.
• Disclosure — Disclosure is required for each presenting author, as well as agreement with Terms and Conditions.
• Review Work — There is a “Preview Abstract”.
  • Please proofread before submission to avoid errors.
• Submit — All tasks must be completed and the abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. A confirmation email will be sent.

Note — Abstracts cannot contain advertising, trade names or a product-group messaging. Include generic names or terms in your abstract content. If the abstract includes trade names, names from several companies should be used — not just trade names from a single company — to present all available treatment options. If trade names or company names are included in your abstract, the AANS reserves the right to remove them to ensure all scientific content is free from commercial bias.

• Yes, you can make edits until the submission deadline.
• Once the review process begins, no changes to the submitted abstracts are allowed — no exceptions. Please note that any typographical or spelling errors, improperly formatted titles, missing co-authors, etc., will notbe edited by anyone at the AANS.
• It is the responsibility of the submitter to review and verify all work submitted. Please remember, after making any changes to your abstract, you must save and resubmitthe abstract, even if it was previously submitted. The abstract status must read “COMPLETE” on the submission site home screen for the abstract to be included in grading. A confirmation email will be sent for every resubmission.

• Oral Presentations — The highest-ranked abstracts are selected for presentation in one of the plenary, scientific or section sessions. These sessions take place Saturday and Sunday of the meeting. When uploading slide presentations, the aspect ratio should be 16:9.
  • The oral presentation slide upload site opens Monday, March 20, 2023.
• E-posters — E-posters are a digital presentation of an abstract and can be viewed through the entirety of the AANS Annual Scientific Meeting on the meeting app, at app kiosks in the designated e-poster area at the convention center and on the virtual platform. Presenting authors have the opportunity to upload a supplemental PDF poster or a prerecorded video slide presentation to accompany their original abstract submission.
  • Late-breaking abstracts are not eligible for E-poster presentations.
  • The e-poster upload site opens Friday, February 24 and closes Monday, March 31, 2023. Late uploads are not accepted — no exceptions.

• All abstract submitters will be notified by email in early-January 2023 of their abstract status.
• Late-breaking submitters will be notified by email mid-March 2023.

• Yes, all presenting authors are required to register and pay for the annual meeting.
  • With acceptance to present an oral presentation or late-breaking presentation, the presenting author must register and attend the 2023 AANS Annual Scientific Meeting in Los Angeles.
  • With acceptance to present an e-poster presentation, the presenting author must register and attend the 2023 AANS Annual Scientific Meeting in Los Angeles.

Registration must be completed by Monday, February 20, 2023. If the presenting author does not complete registration by above date, all accepted abstracts submitted by the presenting author will be declined.

Registration for late-breaking abstracts must be completed by Friday, March 17, 2023. If the presenting author does not complete registration by above date, the accepted Late-breaking abstract submitted by the presenting author will be declined.

• No, the AANS does not allow for any charts, graphs or images in the abstract submission process.

• All oral presentations including late-breaking presentations are available live and in the meeting app.
• E-poster abstracts are available on the virtual platform and in the meeting app. Kiosks displaying the app are located in a designated area at the convention center.
• All abstracts will be published in the meeting app and virtual platform exactly as they are submitted, no exceptions – proofread before it is submitted to avoid errors.

Each submission is blindly reviewed by neurosurgeons whose specialty is within the category of submission.